Arteriosclerosis and Thrombosis, Vol 14, 1129-1136, Copyright © 1994 by American Heart Association

ARTICLES

Increased plasma cholesteryl ester transfer protein in obese subjects. A possible mechanism for the reduction of serum HDL cholesterol levels in obesity

T Arai, S Yamashita, K Hirano, N Sakai, K Kotani, S Fujioka, S Nozaki, Y Keno, M Yamane and E Shinohara
Second Department of Internal Medicine, Osaka University Medical School, Japan.

It is well known that obesity is frequently associated with low levels of serum high-density lipoprotein (HDL) cholesterol. However, the mechanism for this reduction has not been fully clarified. Cholesteryl ester transfer protein (CETP) transfers cholesteryl ester from HDL to apolipoprotein B-containing lipoproteins and plays an important role in regulating the concentration and composition of HDL. To elucidate the mechanism for the reduction of serum HDL cholesterol in obesity, we analyzed serum lipoproteins, CETP, and postheparin lipoprotein lipase (LPL) and hepatic triglyceride lipase (HTGL) activities in 30 obese subjects (17 women and 13 men, age 44 +/- 14 years, mean +/- SD). We also investigated the relationship between these variables, total adiposity, and indices of body fat distribution. The average body mass index of the obese subjects was 33.1 +/- 4.8 kg/m2 (range, 26.4 to 43.8 kg/m2). The obese subjects showed significantly lower serum HDL cholesterol levels than control subjects (1.04 +/- 0.28 versus 1.50 +/- 0.34 mmol/L, P < .01). In the obese subjects, both activities and protein mass of CETP and postheparin HTGL activities were significantly increased, whereas postheparin LPL activities were significantly decreased. CETP activities, independent of postheparin HTGL and LPL activities, were correlated negatively with HDL cholesterol (r = -.39, P < .05) and the cholesteryl ester to triglyceride ratio of HDL2 and HDL3 (r = -.36, P < .05; r = -.46, P < .05, respectively).(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				A. Bakhai Adipokines--targeting a root cause of cardiometabolic risk QJM, October 1, 2008; 101(10): 767 - 776. [Abstract] [Full Text] [PDF]

				M. E. Lira, A. K. Loomis, S. A. Paciga, D. B. Lloyd, and J. F. Thompson Expression of CETP and of splice variants induces the same level of ER stress despite secretion efficiency differences J. Lipid Res., September 1, 2008; 49(9): 1955 - 1962. [Abstract] [Full Text] [PDF]

				H. Zhou, Z. Li, M. R. Hojjati, D. Jang, T. P. Beyer, G. Cao, A. R. Tall, and X.-C. Jiang Adipose tissue-specific CETP expression in mice: impact on plasma lipoprotein metabolism J. Lipid Res., September 1, 2006; 47(9): 2011 - 2019. [Abstract] [Full Text] [PDF]

				A. H.E.M. Klerkx, K. E. Harchaoui, W. A. van der Steeg, S. M. Boekholdt, E. S.G. Stroes, J. J.P. Kastelein, and J. A. Kuivenhoven Cholesteryl Ester Transfer Protein (CETP) Inhibition Beyond Raising High-Density Lipoprotein Cholesterol Levels: Pathways by Which Modulation of CETP Activity May Alter Atherogenesis Arterioscler Thromb Vasc Biol, April 1, 2006; 26(4): 706 - 715. [Abstract] [Full Text] [PDF]

				S. E. Borggreve, H. L. Hillege, B. H. R. Wolffenbuttel, P. E. de Jong, S. J. L. Bakker, G. van der Steege, A. van Tol, R. P. F. Dullaart, and on behalf of the PREVEND Study Group The Effect of Cholesteryl Ester Transfer Protein -629C->A Promoter Polymorphism on High-Density Lipoprotein Cholesterol Is Dependent on Serum Triglycerides J. Clin. Endocrinol. Metab., July 1, 2005; 90(7): 4198 - 4204. [Abstract] [Full Text] [PDF]

				G D Kolovou, K K Anagnostopoulou, and D V Cokkinos Pathophysiology of dyslipidaemia in the metabolic syndrome Postgrad. Med. J., June 1, 2005; 81(956): 358 - 366. [Abstract] [Full Text] [PDF]

				P. S. MacLean, S. Vadlamudi, K. G. MacDonald, W. J. Pories, and H. A. Barakat Suppression of Hepatic Cholesteryl Ester Transfer Protein Expression in Obese Humans with the Development of Type 2 Diabetes Mellitus J. Clin. Endocrinol. Metab., April 1, 2005; 90(4): 2250 - 2258. [Abstract] [Full Text] [PDF]

				G. Ferretti, T. Bacchetti, C. Moroni, S. Savino, A. Liuzzi, F. Balzola, and V. Bicchiega Paraoxonase Activity in High-Density Lipoproteins: A Comparison between Healthy and Obese Females J. Clin. Endocrinol. Metab., March 1, 2005; 90(3): 1728 - 1733. [Abstract] [Full Text] [PDF]

				C.F. Ebenbichler, M. Laimer, S. Kaser, A. Ritsch, A. Sandhofer, H. Weiss, F. Aigner, and J.R. Patsch Relationship Between Cholesteryl Ester Transfer Protein and Atherogenic Lipoprotein Profile in Morbidly Obese Women Arterioscler Thromb Vasc Biol, September 1, 2002; 22(9): 1465 - 1469. [Abstract] [Full Text] [PDF]

				S. Khan, A.-M. Minihane, P. J. Talmud, J. W. Wright, M. C. Murphy, C. M. Williams, and B. A. Griffin Dietary long-chain n-3 PUFAs increase LPL gene expression in adipose tissue of subjects with an atherogenic lipoprotein phenotype J. Lipid Res., June 1, 2002; 43(6): 979 - 985. [Abstract] [Full Text] [PDF]

				B. L. Wajchenberg Subcutaneous and Visceral Adipose Tissue: Their Relation to the Metabolic Syndrome Endocr. Rev., December 1, 2000; 21(6): 697 - 738. [Abstract] [Full Text]

				J. Q. Purnell, S. E. Kahn, J. J. Albers, D. N. Nevin, J. D. Brunzell, and R. S. Schwartz Effect of Weight Loss with Reduction of Intra-Abdominal Fat on Lipid Metabolism in Older Men J. Clin. Endocrinol. Metab., March 1, 2000; 85(3): 977 - 982. [Abstract] [Full Text]

				S. C. Riemens, A. Van Tol, B. K. Stulp, and R. P. F. Dullaart Influence of insulin sensitivity and the TaqIB cholesteryl ester transfer protein gene polymorphism on plasma lecithin:cholesterol acyltransferase and lipid transfer protein activities and their response to hyperinsulinemia in non-diabetic men J. Lipid Res., August 1, 1999; 40(8): 1467 - 1474. [Abstract] [Full Text]

				T. Rönnemaa, J. Marniemi, M. J. Savolainen, Y. A. Kesäniemi, C. Ehnholm, C. Bouchard, and M. Koskenvuo Serum Lipids, Lipoproteins, and Lipid Metabolizing Enzymes in Identical Twins Discordant for Obesity J. Clin. Endocrinol. Metab., August 1, 1998; 83(8): 2792 - 2799. [Abstract] [Full Text]

				K. Sasai, K. Okumura-Noji, T. Hibino, R. Ikeuchi, N. Sakuma, T. Fujinami, and S. Yokoyama Human cholesteryl ester transfer protein measured by enzyme-linked immunosorbent assay with two monoclonal antibodies against rabbit cholesteryl ester transfer protein: plasma cholesteryl ester transfer protein and lipoproteins among Japanese hypercholesterolemic patients Clin. Chem., July 1, 1998; 44(7): 1466 - 1473. [Abstract] [Full Text] [PDF]

				B. Foger, A. Ritsch, A. Doblinger, H. Wessels, and J. R. Patsch Relationship of Plasma Cholesteryl Ester Transfer Protein to HDL Cholesterol: Studies in Normotriglyceridemia and Moderate Hypertriglyceridemia Arterioscler Thromb Vasc Biol, December 1, 1996; 16(12): 1430 - 1436. [Abstract] [Full Text]

				M. C. Mahaney, J. Blangero, A. G. Comuzzie, J. L. VandeBerg, M. P. Stern, and J. W. MacCluer Plasma HDL Cholesterol, Triglycerides, and Adiposity : A Quantitative Genetic Test of the Conjoint Trait Hypothesis in the San Antonio Family Heart Study Circulation, December 1, 1995; 92(11): 3240 - 3248. [Abstract] [Full Text]